• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

Poll: Biden’s vaccine mandate (unsurprisingly) splits Americans on party lines

By
Carla K. Johnson
Carla K. Johnson
,
The Associated Press
The Associated Press
, and
Hannah Fingerhut
Hannah Fingerhut
Down Arrow Button Icon
By
Carla K. Johnson
Carla K. Johnson
,
The Associated Press
The Associated Press
, and
Hannah Fingerhut
Hannah Fingerhut
Down Arrow Button Icon
September 30, 2021, 10:55 AM ET

A survey of Americans on President Joe Biden’s plan to require most workers to get either vaccinated or regularly tested for COVID-19 finds a deep and familiar divide: Democrats are overwhelmingly for it, while most Republicans are against it.

With the highly contagious Delta variant driving deaths up to around 2,000 per day, the poll released Thursday by The Associated Press-NORC Center for Public Affairs Research showed that overall, 51% say they approve of the Biden requirement, 34% disapprove and 14% hold neither opinion.

About three quarters of Democrats, but only about a quarter of Republicans, approve. Roughly 6 in 10 Republicans say they disapprove. Over the course of the outbreak, Democrats and Republicans in many places have also found themselves divided over masks and other precautions.

“I don’t believe the federal government should have a say in me having to get the vaccine or lose my job or get tested,” said 28-year-old firefighter Emilio Rodriguez in Corpus Christi, Texas. The Republican is not vaccinated.

Democrat and retired school secretary Sarah Carver, 70, strongly approves of the Biden mandate. The suburban Cleveland resident said she wants more people vaccinated to protect her 10-year-old grandson, who is too young to get the shot, and her vaccinated husband, who has breathing problems and Alzheimer’s disease.

“I believe Dr. Fauci,” Carver said, referring to Dr. Anthony Fauci, the government’s top infectious disease specialist. Carver has had two doses of the Moderna vaccine.

Sixty-four percent of vaccinated Americans say they approve of the mandate, while 23% disapprove. Among unvaccinated Americans, just 14% are in support, while 67% are opposed. Most remote employees approve, but in-person workers are about evenly divided.

Exactly how the mandate will work is still being hammered out by the Occupational Safety and Health Administration. Some health experts have said weekly testing is a poor substitute for vaccination but a necessary part of the policy.

“Testing is used here to make it inconvenient” to avoid vaccination, said immunologist Gigi Gronvall, a senior scholar at the Johns Hopkins Center for Health Security. The choice will be: “You can get your two doses of vaccine, or here’s what you’re going to be doing every week.”

The hope, Gronvall said, is that mandates will force people who have procrastinated to join the 56% of the U.S. population now fully vaccinated.

The testing choice makes the Biden workplace mandate more palatable to Cassie Tremant, a 32-year-old volunteer for a wildlife rescue group in Austin, Texas. She agrees with the mandate as long as people can opt out by getting tested weekly. A Democrat, she is fully vaccinated. Her grandmother was hospitalized with COVID-19.

“Personally, I would prefer everybody to be vaccinated,” Tremant said. The Biden plan “gives people an option. If they don’t comply, it’s on them to get tested. I think it’s a fair rule.”

Roughly two-thirds of Americans say they are at least somewhat worried about themselves or family members becoming infected with the virus, though intense worry has declined. About 3 in 10 are now very or extremely worried, compared with about 4 in 10 in mid-August.

About two-thirds of Americans are at least somewhat confident the COVID-19 vaccines will be effective against virus variants.

A new AP-NORC poll finds more Democrats than Republicans support President Joe Biden’s plan requiring a COVID-19 vaccine or testing for U.S. workers. Americans working in person are closely divided.
AP Photo

Americans remain most trusting of health professionals for information about the vaccines, largely unchanged from December. Roughly 8 in 10 trust their doctors and other health care providers at least a moderate amount.

Rodriguez, the Corpus Christi firefighter, said he distrusts government vaccine information because it appears to him to be overly rosy.

“I’ve heard nothing negative about getting it at all,” he said. “Nothing about side effects. It’s ‘No, everything’s fine. Go ahead and go get it.’”

The Centers for Disease Control and Prevention does list common side effects of the vaccines such as tiredness, muscle pain, fever, chills and nausea. Serious problems are rare, including heart inflammation that can occur in young men.

If he is subject to a workplace mandate, Rodriguez said, he will consult his doctor, whom he trusts.

Public trust in the top U.S. science agencies for vaccine information is also relatively high. Roughly 7 in 10 trust the CDC and the Food and Drug Administration at least a moderate amount.

“They’re the scientists and they know what they’re talking about,” said Ohio retiree Carver. “They’re not quacks like some you see on the internet.”

In contrast, only about 4 in 10 Americans say they trust the news media a moderate amount or more for information about the vaccines; about 6 in 10 have little or no trust in the media.

A majority of Americans approve of Biden’s handling of COVID-19, though his rating is lower than it was during the first six months of his presidency. Fifty-seven percent approve, while 43% disapprove. That’s similar to his ratings last month. As recently as July, roughly two-thirds approved of Biden’s handling of the pandemic.

Close to half don’t trust the president for information about vaccines. That includes Democrat Tremant, the Austin wildlife rescue volunteer.

“Politicians say really dumb stuff,” Tremant said. “I would never trust any medical guidance or advice from any politician, even if they’re my favorite politician in the world.”

The AP-NORC poll of 1,099 adults was conducted Sept. 23-27 using a sample drawn from NORC’s probability-based AmeriSpeak Panel, which is designed to be representative of the U.S. population. The margin of sampling error for all respondents is plus or minus 4.2 percentage points.

More health care and Big Pharma coverage from Fortune:

  • Health insurers justify passing COVID treatment costs on to patients despite massive profits
  • Why pregnant people are now eligible for COVID-19 vaccine boosters
  • Portugal leads the world in COVID-19 vaccinations
  • A WHO-approved Novavax vaccine could upstage mRNA jabs—if it can solve its manufacturing delays
  • Duckworth, Raimondo: Congress must back the president’s historic investment in home care workers

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.

About the Authors
By Carla K. Johnson
See full bioRight Arrow Button Icon
By The Associated Press
See full bioRight Arrow Button Icon
By Hannah Fingerhut
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Simple App Review (2026): Expert Tested and Reviewed
Healthmeal delivery
Simple App Review (2026): Expert Tested and Reviewed
By Emily PharesApril 30, 2026
1 day ago
Premium card perks are ‘designed to create a win-win-win for everyone’ but customers are paying with heavy annual fees and data
Personal FinancePersonal Finance Evergreen
Premium card perks are ‘designed to create a win-win-win for everyone’ but customers are paying with heavy annual fees and data
By Catherina GioinoApril 30, 2026
1 day ago
hoskins
Commentaryoffices
Gensler Co-Chair: Hot-desking was supposed to save money. It may be costing you your culture
By Diane HoskinsApril 30, 2026
2 days ago
raw milk
Politicsmilk
Risk of paralysis, bacteria, even death is no match for Americans’ thirst for raw milk
By Laura Ungar, Jonel Aleccia and The Associated PressApril 29, 2026
2 days ago
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
HealthDietary Supplements
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
By Christina SnyderApril 29, 2026
3 days ago
aging
HealthLongevity
We’re the CEOs of Peloton and the Hospital for Special Surgery. Living longer isn’t enough, we need to live better, too
By Bryan T. Kelly and Peter SternApril 29, 2026
3 days ago

Most Popular

Scott Bessent on financial literacy: 'it drives me crazy' to see young men in blue-collar construction jobs playing the lottery
Personal Finance
Scott Bessent on financial literacy: 'it drives me crazy' to see young men in blue-collar construction jobs playing the lottery
By Fatima Hussein and The Associated PressMay 1, 2026
14 hours ago
China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
North America
China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
By Jake AngeloApril 30, 2026
1 day ago
The U.S. economy is booming — just not where 50 million Americans live
Commentary
The U.S. economy is booming — just not where 50 million Americans live
By Derek KilmerMay 1, 2026
18 hours ago
Accenture's Julie Sweet blew up 50 years of company history. She says the hardest part is still ahead
Conferences
Accenture's Julie Sweet blew up 50 years of company history. She says the hardest part is still ahead
By Nick LichtenbergApril 29, 2026
3 days ago
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
By Preston ForeApril 27, 2026
4 days ago
Current price of oil as of May 1, 2026
Personal Finance
Current price of oil as of May 1, 2026
By Joseph HostetlerMay 1, 2026
14 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.